Informação sobre produto
- (.+-.)-Verapamil
- 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile
- 2-(3,4-Dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]-2-(propan-2-yl)pentanenitrile
- 2-(3,4-Dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]-2-isopropylpentanenitrile
- 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxy phenyl)-2-isopropylvaleronitrile
- Cp 16533-1
- D 365
- Iproveratril
- Lekoptin
- Nsc 272306Na
- Ver mais sinónimos
- R,S-Verapamil
- VPL
- Valeronitrile, 5-[(3,4-dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropyl-
- Verapamilo
- dl-Verapamil
- α-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-α-(1-methylethyl)benzeneacetonitrile
- Benzeneacetonitrile, α-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-α-(1-methylethyl)-
Verapamil is a calcium antagonist that blocks the influx of extracellular calcium and inhibits the release of calcium from intracellular storage sites. Verapamil may be used to treat hypertension, angina pectoris, and arrhythmias. This drug is also used as a diagnostic agent in studies of the cardiovascular system. Verapamil has been shown to reduce ventricular systolic dysfunction and cardiovascular morbidity in patients with chronic heart failure. The elimination half-life of verapamil ranges from 5 to 8 hours, depending on dose. It is eliminated primarily by renal excretion with less than 1% being metabolized in the liver.
Propriedades químicas
Consulta técnica sobre: 3D-FV02354 Verapamil
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.